- Filed
- Jan 23, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Jan 22, 2026 | 150.12M sh |
| Shares Diluted | Q3 2026 · Oct 31, 2025 | 142.51M sh |
| Shares Diluted | Q3 2026 · Oct 31, 2025 | 142.43M sh |
| Shares Diluted | Q3 2026 · Oct 31, 2024 | 138.34M sh |
| Shares Diluted | Q3 2026 · Oct 31, 2024 | 138.89M sh |
| Stock Repurchased | Q3 2026 · Oct 31, 2025 | $265K |
| Stock Repurchased | Q3 2026 · Oct 31, 2024 | $23.48M |
| Operating Cash Flow | Q3 2026 · Oct 31, 2025 | $118.88M |
| Operating Cash Flow | Q3 2026 · Oct 31, 2024 | $103.24M |
| Cash And Equivalents | Q3 2026 · Oct 31, 2025 | $266.19M |
| Cash And Equivalents | Q3 2026 · Jan 31, 2025 | $142.86M |
| Cash And Equivalents | Q3 2026 · Oct 31, 2024 | $132.86M |
| Stockholders Equity | Q3 2026 · Oct 31, 2025 | $125.36M |
| Stockholders Equity | Q3 2026 · Jul 31, 2025 | $84.36M |
| Stockholders Equity | Q3 2026 · Jan 31, 2025 | $15.34M |
| Stockholders Equity | Q3 2026 · Oct 31, 2024 | −$30.93M |
| Stockholders Equity | Q3 2026 · Jul 31, 2024 | −$42.46M |
| Stockholders Equity | Q3 2026 · Jan 31, 2024 | −$180.86M |
| Current Liabilities | Q3 2026 · Oct 31, 2025 | $440.84M |
| Current Liabilities | Q3 2026 · Jan 31, 2025 | $173.22M |
| Total Liabilities | Q3 2026 · Oct 31, 2025 | $458.08M |
| Total Liabilities | Q3 2026 · Jan 31, 2025 | $192.67M |
| Current Assets | Q3 2026 · Oct 31, 2025 | $742.78M |
| Current Assets | Q3 2026 · Jan 31, 2025 | $346.45M |
| Total Assets | Q3 2026 · Oct 31, 2025 | $810.64M |
| Total Assets | Q3 2026 · Jan 31, 2025 | $435.21M |
| Eps Diluted | Q3 2026 · Oct 31, 2025 | $0.21 |
| Eps Diluted | Q3 2026 · Oct 31, 2025 | $0.64 |
| Eps Diluted | Q3 2026 · Oct 31, 2024 | $0.22 |
| Eps Diluted | Q3 2026 · Oct 31, 2024 | $1.08 |
| Eps Basic | Q3 2026 · Oct 31, 2025 | $0.72 |
| Eps Basic | Q3 2026 · Oct 31, 2025 | $2.22 |
| Eps Basic | Q3 2026 · Oct 31, 2024 | $0.77 |
| Eps Basic | Q3 2026 · Oct 31, 2024 | $4.17 |
| Sga Expense | Q3 2026 · Oct 31, 2025 | $15.4M |
| Sga Expense | Q3 2026 · Oct 31, 2025 | $34.14M |
| Sga Expense | Q3 2026 · Oct 31, 2024 | $7.37M |
| Sga Expense | Q3 2026 · Oct 31, 2024 | $21.25M |
| Rd Expense | Q3 2026 · Oct 31, 2025 | $20.92M |
| Rd Expense | Q3 2026 · Oct 31, 2025 | $62.38M |
| Rd Expense | Q3 2026 · Oct 31, 2024 | $17.06M |
| Rd Expense | Q3 2026 · Oct 31, 2024 | $46.43M |
| Net Income | Q3 2026 · Oct 31, 2025 | $30.9M |
| Net Income | Q3 2026 · Oct 31, 2025 | $91.59M |
| Net Income | Q3 2026 · Oct 31, 2024 | $30.05M |
| Net Income | Q3 2026 · Oct 31, 2024 | $162.36M |
| Cost Of Revenue | Q3 2026 · Oct 31, 2025 | $10.18M |
| Cost Of Revenue | Q3 2026 · Oct 31, 2025 | $28.43M |
| Cost Of Revenue | Q3 2026 · Oct 31, 2024 | $7.99M |
| Cost Of Revenue | Q3 2026 · Oct 31, 2024 | $22.42M |
| Revenue | Q3 2026 · Oct 31, 2025 | $93.22M |
| Revenue | Q3 2026 · Oct 31, 2025 | $268.86M |
| Revenue | Q3 2026 · Oct 31, 2024 | $80.31M |
| Revenue | Q3 2026 · Oct 31, 2024 | $226.18M |